Ayehunie S, Sönnerborg A, Desta B, Kefene H, Zewdie D, Britton S, Strannegård O
Department of Biology, Addis Ababa University, Ethiopia.
AIDS. 1992 Jul;6(7):651-7. doi: 10.1097/00002030-199207000-00006.
To determine the relationship and occurrence of cell-free viraemia, free or immune-complexed p24-antigen and p24-antibody levels in blood from HIV-1-infected patients in Ethiopia.
Peripheral blood was obtained from 66 Ethiopian and 137 Swedish HIV-1-seropositive patients. Blood samples were analysed for free or immune-complex bound p24 antigen by enzyme-linked immunosorbent assay before and after acid hydrolysis of immune complexes for infectious virus in plasma and peripheral blood mononuclear cells (PBMC), and for p24-antibody levels. We compared the kinetics of viral replication of Ethiopian with Swedish isolates in vitro.
Infectious virus was isolated from PBMC in 95% and from plasma in 81% of Ethiopian AIDS patients. In contrast, p24 antigen was detected in only 5% of AIDS patients from Ethiopia, compared with 76% of those from Sweden. p24-antibody levels were much higher and more persistent in Ethiopian than in Swedish subjects. The ratio between reverse transcriptase activity and p24 antigen was significantly higher in Ethiopian isolate culture than in those of the Swedish isolates.
Our results show that relationships between viraemia, p24 antigenaemia and p24-antibody levels in HIV-1-infected Ethiopian patients differ from those found in comparable Swedish patients. This pattern may partly explain the differences seen in the natural course of HIV-1 infection in Ethiopia and Sweden.
确定埃塞俄比亚HIV-1感染患者血液中游离病毒血症、游离或免疫复合物形式的p24抗原及p24抗体水平之间的关系及出现情况。
从66名埃塞俄比亚和137名瑞典HIV-1血清阳性患者获取外周血。对血液样本进行分析,通过酶联免疫吸附测定法检测免疫复合物酸水解前后血浆和外周血单个核细胞(PBMC)中游离或免疫复合物结合的p24抗原,以及p24抗体水平。我们在体外比较了埃塞俄比亚分离株与瑞典分离株的病毒复制动力学。
95%的埃塞俄比亚艾滋病患者的PBMC中分离出感染性病毒,81%的患者血浆中分离出感染性病毒。相比之下,埃塞俄比亚仅5%的艾滋病患者检测到p24抗原,而瑞典为76%。埃塞俄比亚患者的p24抗体水平比瑞典患者更高且更持久。埃塞俄比亚分离株培养物中逆转录酶活性与p24抗原的比值显著高于瑞典分离株。
我们的结果表明,HIV-1感染的埃塞俄比亚患者中病毒血症、p24抗原血症和p24抗体水平之间的关系与瑞典类似患者不同。这种模式可能部分解释了埃塞俄比亚和瑞典HIV-1感染自然病程中所见的差异。